Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers
Go back to Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers| (NASDAQ: UNCY) | Delayed: 5.29 -0.02 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.31 | 52 Week High | $ | |||
| Open | $5.34 | 52 Week Low | $ | |||
| Day High | $5.40 | P/E | N/A | |||
| Day Low | $5.22 | EPS | $ | |||
| Volume | 1,116,677 | |||||
